We are live on ! Find out more
OP

Omni Partners Portfolio holdings

AUM $2.03B
1-Year Est. Return 126.33%
This Fund
S&P 500
This Quarter Est. Return
+15.53%
1 Year Est. Return
+126.33%
3 Year Est. Return
+411.65%
5 Year Est. Return
+1,549.93%
10 Year Est. Return
–
AUM
$3.73M
AUM Growth
-$1.38B
Cap. Flow
-$103M
Cap. Flow %
-2,765.76%
Top 10 Hldgs %
92.1%
Holding
54
New
24
Increased
5
Reduced
5
Closed
12

Top Buys

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$154M
2
TGE
Tallgrass Energy, LP Class A Shares
TGE
+$89.1M
3
WCG
Wellcare Health Plans, Inc.
WCG
+$43.3M
4
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$37.1M
5
WMGI
Wright Medical Group Inc
WMGI
+$35.4M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$243M
2
CY
Cypress Semiconductor
CY
+$108M
3
VSM
Versum Materials, Inc.
VSM
+$99.7M
4
BPL
Buckeye Partners, L.P.
BPL
+$45.8M
5
MLNX
Mellanox Technologies, Ltd.
MLNX
+$38.8M

Sector Composition

Rank Sector Weight
1 Technology 37.07%
2 Healthcare 8.3%
3 Consumer Discretionary 4.6%
4 Energy 2.98%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMCXW
51
DELISTED
Trinity Merger Corp. Warrant
TMCXW
– –
-182,100
Closed -$231K
BPL
52
DELISTED
Buckeye Partners, L.P.
BPL
– –
-1,115,000
Closed -$45.8M
VSM
53
DELISTED
Versum Materials, Inc.
VSM
– –
-1,884,409
Closed -$99.7M
CELG
54
DELISTED
Celgene Corp
CELG
– –
-2,445,829
Closed -$243M
1 2
3

Similar funds

BUB
BBVA USA Bancshares Houston, Texas $2.1B AUM 62.57% 1-Year Est. Return
PAG
Pinnacle Advisory Group Columbia, Maryland $2.17B AUM 39.21% 1-Year Est. Return
SBSB
Sullivan, Bruyette, Speros & Blaney Mclean, Virginia $2.27B AUM 50.71% 1-Year Est. Return
PPCM
Pillar Pacific Capital Management Pacifica, California $1.29B AUM 80.18% 1-Year Est. Return
AAM
Anglepoint Asset Management George Town, Cayman Islands $1.28B AUM 131.9% 1-Year Est. Return
ALSV
ATP Life Science Ventures New York $898M AUM 84.86% 1-Year Est. Return
TNB
TCF National Bank Sioux Falls, South Dakota $883M AUM 60.21% 1-Year Est. Return
FIB
First Interstate Bancsystem Billings, Montana $841M AUM

Omni Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Omni Partners held 54 positions worth $3.73M, down 100% from $1.38B the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Omni Partners withdrew a net $103M in Q4 2019, closing 12 positions and reducing 5 holdings. Its most notable exit was Celgene Corp, an estimated $243M position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Omni Partners opened a new position in Medicines Co worth $196K.

  • Omni Partners's largest Q4 2019 buy was Medicines Co: 2,311,536 shares worth $196K.
  • Omni Partners added most to Wellcare Health Plans, Inc. in Q4 2019, an estimated $43.3M increase.
  • Omni Partners's biggest Q4 2019 reduction was Cypress Semiconductor, cutting an estimated $108M.
  • Omni Partners fully exited Celgene Corp in Q4 2019, selling an estimated $243M.
  • Omni Partners's ten largest holdings make up 92% of its $3.73M portfolio in Q4 2019.
  • Omni Partners opened 24 new positions and closed 12 in Q4 2019.
  • Omni Partners's portfolio value fell 100% quarter-over-quarter to $3.73M.

Based on Omni Partners's 13F filing for Q4 2019, filed 13 Feb 2020.